King, Pfizer deal

Pfizer extended to midnight on Dec. 17 from Nov. 19 the deadline for its tender offer to acquire King at $14.25 per share, or $3.6 billion in cash. At Nov. 19, about 187.3 million shares, or 74.9% of ...